Amgen Inc (AMGN) operating KPIs
AMGNNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 5, 2026Score 17/3039% above fair value
$466.01+5.28 (+1.15%)
Close on Oct 30, 2026Market cap $251.94BP/E 28.9Yield 2.07%
Latest, FY2025
-1,943
Period ended Dec 31, 2025
Change on a year earlier
+85.8%
-1,046 in FY2024
History
19 years
Since FY2007
Sources
17
Documents cited below
Annual history
Hover a value to see the sentence it was read from; calculated values show their formula
| Period | Ended | Net cash used in investing activities ($M) ($M) | Year on year | Source |
|---|---|---|---|---|
| FY2025 | Dec 31, 2025 | -1,943 | +85.8% | Form 10-K (filed 2026-02-13) ↗ |
| FY2024 | Dec 31, 2024 | -1,046 | -96.0% | Form 10-K (filed 2025-02-14) ↗ |
| FY2023 | Dec 31, 2023 | -26,204 | +333.6% | Form 10-K (filed 2024-02-14) ↗ |
| FY2022 | Dec 31, 2022 | -6,044 | -924.6% | Form 10-K (filed 2023-02-09) ↗ |
| FY2021 | Dec 31, 2021 | 733 | -113.6% | Form 10-K (filed 2022-02-16) ↗ |
| FY2020 | Dec 31, 2020 | -5,401 | -194.6% | Form 10-K (filed 2021-02-09) ↗ |
| FY2019 | Dec 31, 2019 | 5,709 | -60.2% | Form 10-K (filed 2020-02-12) ↗ |
| FY2018 | Dec 31, 2018 | 14,339 | -456.3% | Form 10-K (filed 2019-02-13) ↗ |
| FY2017 | Dec 31, 2017 | -4,024 | -53.5% | Form 10-K (filed 2018-02-13) ↗ |
| FY2016 | Dec 31, 2016 | -8,658 | +56.1% | Form 10-K (filed 2017-02-14) ↗ |
| FY2015 | Dec 31, 2015 | -5,547 | -3.6% | Form 10-K (filed 2016-02-16) ↗ |
| FY2014 | Dec 31, 2014 | -5,752 | -32.1% | Form 10-K (filed 2015-02-19) ↗ |
| FY2013 | Dec 31, 2013 | -8,469 | -15.2% | Form 10-K (filed 2014-02-24) ↗ |
| FY2012 | Dec 31, 2012 | -9,990 | +1,171.0% | Form 10-K (filed 2013-02-27) ↗ |
| FY2011 | Dec 31, 2011 | -786 | -81.1% | Form 10-K (filed 2012-02-29) ↗ |
| FY2010 | Dec 31, 2010 | -4,152 | +29.7% | Form 10-K (filed 2011-02-25) ↗ |
| FY2009 | Dec 31, 2009 | -3,202 | +1.2% | Form 10-K (filed 2010-03-01) ↗ |
| FY2008 | Dec 31, 2008 | -3,165 | +58.9% | Form 10-K (filed 2010-03-01) ↗ |
| FY2007 | Dec 31, 2007 | -1,992 | – | Form 10-K (filed 2010-03-01) ↗ |
Cite this data
StockData. (2026). Amgen Net cash used in investing activities ($M) ($M), annual FY2007–FY2025 [Data set]. Compiled from Amgen SEC filings and investor materials. https://stockdatahq.com/stocks/amgn/kpis/fs_inv_cf
See every metric in the Amgen KPI table. Data updated Oct 28, 2026.